Texas AG and Johnson & Johnson Battle in Opening Statements
In opening statements today in the state’s $1 billion false drug marketing case against Johnson & Johnson, a lawyer for the company said he will present “real world” evidence that the antipsychotic Risperdal was widely used by medical professionals on adults and children because it works better than competing products.




